Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Treponema pallidum | fructose-bisphosphate aldolase | 0.0347 | 0.0263 | 1 |
Plasmodium vivax | plasmepsin V, putative | 0.0445 | 0.0343 | 0.225 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 1 |
Trypanosoma brucei | lanosterol synthase | 0.0073 | 0.0039 | 0.0039 |
Entamoeba histolytica | acetyltransferase, GNAT family | 0.0046 | 0.0017 | 0.0583 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0167 | 0.0116 | 0.0314 |
Schistosoma mansoni | aminoadipate-semialdehyde dehydrogenase | 0.0099 | 0.006 | 0.0103 |
Toxoplasma gondii | aspartyl protease ASP1 | 0.1883 | 0.1517 | 1 |
Schistosoma mansoni | hypothetical protein | 0.3826 | 0.3103 | 0.6868 |
Echinococcus granulosus | L aminoadipate semialdehyde | 0.0099 | 0.006 | 0.0132 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Entamoeba histolytica | fructose-1,6-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 1 |
Trypanosoma brucei | unspecified product | 0.0041 | 0.0013 | 0.0013 |
Trypanosoma cruzi | squalene monooxygenase, putative | 0.0571 | 0.0446 | 0.0427 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0066 | 0.0034 | 0.0095 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0049 | 0.0019 | 0.0055 |
Plasmodium falciparum | plasmepsin VIII, putative | 0.0445 | 0.0343 | 0.225 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 0.0343 | 0.1077 |
Schistosoma mansoni | memapsin-2 (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Plasmodium vivax | conserved Plasmodium protein, unknown function | 0.0048 | 0.0019 | 0.011 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Plasmodium falciparum | plasmepsin VI | 0.1883 | 0.1517 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0066 | 0.0034 | 0.0095 |
Plasmodium falciparum | protein farnesyltransferase subunit beta | 0.0066 | 0.0034 | 0.0207 |
Echinococcus granulosus | microtubule associated protein 2 | 0.082 | 0.0649 | 0.2042 |
Mycobacterium ulcerans | fructose-bisphosphate aldolase | 0.017 | 0.0118 | 0.0374 |
Plasmodium vivax | aspartyl protease, putative | 0.0445 | 0.0343 | 0.225 |
Brugia malayi | Eukaryotic aspartyl protease family protein | 0.0445 | 0.0343 | 1 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-B | 0.0051 | 0.0021 | 0.0123 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Trichomonas vaginalis | geranylgeranyl transferase type beta subunit, putative | 0.0066 | 0.0034 | 0.0095 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0049 | 0.0019 | 0.0019 |
Trichomonas vaginalis | geranylgeranyl transferase type II beta subunit, putative | 0.0066 | 0.0034 | 0.0095 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Plasmodium falciparum | histone acetyltransferase GCN5 | 0.0046 | 0.0017 | 0.01 |
Loa Loa (eye worm) | aspartic protease BmAsp-1 | 0.0445 | 0.0343 | 0.1077 |
Trypanosoma brucei | squalene monooxygenase, putative | 0.0571 | 0.0446 | 0.0446 |
Loa Loa (eye worm) | prenyltransferase and squalene oxidase repeat family protein | 0.0066 | 0.0034 | 0.0077 |
Loa Loa (eye worm) | aspartic protease BmAsp-2 | 0.1883 | 0.1517 | 0.4872 |
Loa Loa (eye worm) | hypothetical protein | 0.3826 | 0.3103 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0105 | 0.0065 | 0.0179 |
Leishmania major | lanosterol synthase, putative | 0.0055 | 0.0024 | 0.0024 |
Echinococcus multilocularis | L aminoadipate semialdehyde | 0.0099 | 0.006 | 0.0132 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Brugia malayi | hypothetical protein | 0.0105 | 0.0065 | 0.166 |
Echinococcus multilocularis | Squalene phytoene synthase | 0.3826 | 0.3103 | 1 |
Echinococcus multilocularis | gcn5proteinral control of amino acid synthesis | 0.0172 | 0.012 | 0.0327 |
Plasmodium falciparum | plasmepsin V | 0.0445 | 0.0343 | 0.225 |
Trichomonas vaginalis | type I geranylgeranyltransferase beta subunit, putative | 0.0066 | 0.0034 | 0.0095 |
Echinococcus granulosus | tachykinin peptides receptor 99D | 0.0299 | 0.0224 | 0.0662 |
Trichomonas vaginalis | bromodomain-containing protein, putative | 0.0051 | 0.0021 | 0.001 |
Mycobacterium ulcerans | phytoene synthase, CrtB | 0.3826 | 0.3103 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0105 | 0.0065 | 0.0179 |
Plasmodium vivax | aspartyl protease, putative | 0.0445 | 0.0343 | 0.225 |
Brugia malayi | Prenyltransferase and squalene oxidase repeat family protein | 0.0066 | 0.0034 | 0.0717 |
Mycobacterium tuberculosis | Halimadienyl diphosphate synthase | 0.0073 | 0.0039 | 0.0125 |
Trichomonas vaginalis | cat eye syndrome critical region protein 2, cscr2, putative | 0.0051 | 0.0021 | 0.001 |
Mycobacterium tuberculosis | Probable phytoene synthase PhyA | 0.3826 | 0.3103 | 1 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0028 | 0.0002 | 0.0002 |
Echinococcus granulosus | protein farnesyltransferase subunit beta | 0.0066 | 0.0034 | 0.0046 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0041 | 0.0013 | 0.0013 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0049 | 0.0019 | 0.0019 |
Echinococcus multilocularis | protein farnesyltransferase subunit beta | 0.0066 | 0.0034 | 0.0046 |
Loa Loa (eye worm) | aspartyl protease 6 | 0.0445 | 0.0343 | 0.1077 |
Trichomonas vaginalis | geranylgeranyl transferase type I beta subunit, putative | 0.0066 | 0.0034 | 0.0095 |
Schistosoma mansoni | gcn5proteinral control of amino-acid synthesis 5-like 2 gcnl2 | 0.0172 | 0.012 | 0.0237 |
Loa Loa (eye worm) | hypothetical protein | 0.0445 | 0.0343 | 0.1077 |
Giardia lamblia | Fructose-bisphosphate aldolase | 0.0347 | 0.0263 | 1 |
Giardia lamblia | Histone acetyltransferase GCN5 | 0.0046 | 0.0017 | 0.0664 |
Loa Loa (eye worm) | hypothetical protein | 0.1883 | 0.1517 | 0.4872 |
Plasmodium falciparum | plasmepsin IV | 0.1883 | 0.1517 | 1 |
Wolbachia endosymbiont of Brugia malayi | 4'-phosphopantetheinyl transferase | 0.0028 | 0.0002 | 0.5 |
Mycobacterium tuberculosis | Probable fructose-bisphosphate aldolase Fba | 0.017 | 0.0118 | 0.038 |
Echinococcus granulosus | histone acetyltransferase KAT2B | 0.0051 | 0.0021 | 0.0005 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Plasmodium falciparum | plasmepsin II | 0.1883 | 0.1517 | 1 |
Leishmania major | hypothetical protein, conserved | 0.3826 | 0.3103 | 0.3103 |
Plasmodium falciparum | plasmepsin I | 0.1883 | 0.1517 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Echinococcus granulosus | cathepsin d lysosomal aspartyl protease | 0.1883 | 0.1517 | 0.4856 |
Schistosoma mansoni | eyes absent homolog | 0.0105 | 0.0065 | 0.0114 |
Leishmania major | farnesyltransferase beta subunit | 0.0066 | 0.0034 | 0.0034 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0066 | 0.0034 | 0.0014 |
Trypanosoma cruzi | squalene synthase, putative | 1.2275 | 1 | 1 |
Onchocerca volvulus | NADH dehydrogenase (ubiquinone) complex I, assembly factor 6 homolog | 0.3826 | 0.3103 | 1 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.5552 | 0.4512 | 1 |
Plasmodium falciparum | plasmepsin VII | 0.0445 | 0.0343 | 0.225 |
Schistosoma mansoni | protein farnesyltransferase subunit beta | 0.0066 | 0.0034 | 0.0044 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.001 | 0.001 |
Mycobacterium ulcerans | DNA polymerase IV | 0.0049 | 0.0019 | 0.0055 |
Trypanosoma cruzi | protein farnesyltransferase, putative | 0.0066 | 0.0034 | 0.0014 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0073 | 0.0039 | 0.0019 |
Trypanosoma cruzi | phytoene synthase, putative | 0.3826 | 0.3103 | 0.3089 |
Plasmodium vivax | aspartyl proteinase, putative | 0.1883 | 0.1517 | 1 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Schistosoma mansoni | cathepsin D (A01 family) | 0.5552 | 0.4512 | 1 |
Loa Loa (eye worm) | acetyltransferase | 0.0172 | 0.012 | 0.0357 |
Onchocerca volvulus | 0.0445 | 0.0343 | 0.0929 | |
Loa Loa (eye worm) | hypothetical protein | 0.0099 | 0.006 | 0.0163 |
Toxoplasma gondii | eukaryotic aspartyl protease superfamily protein | 0.0445 | 0.0343 | 0.225 |
Brugia malayi | acetyltransferase, GNAT family protein | 0.0172 | 0.012 | 0.3314 |
Schistosoma mansoni | microtubule-associated protein tau | 0.082 | 0.0649 | 0.1412 |
Mycobacterium leprae | Probable fructose bisphosphate aldolase Fba | 0.017 | 0.0118 | 1 |
Trypanosoma cruzi | squalene monooxygenase, putative | 0.0571 | 0.0446 | 0.0427 |
Trichomonas vaginalis | Clan AA, family A1, cathepsin D-like aspartic peptidase | 0.1883 | 0.1517 | 1 |
Trypanosoma brucei | squalene synthase, putative | 1.2275 | 1 | 1 |
Toxoplasma gondii | aspartyl protease ASP3 | 0.0445 | 0.0343 | 0.225 |
Toxoplasma gondii | prenyltransferase and squalene oxidase repeat-containing protein | 0.0066 | 0.0034 | 0.0207 |
Echinococcus multilocularis | microtubule associated protein 2 | 0.082 | 0.0649 | 0.2042 |
Trypanosoma brucei | protein farnesyltransferase beta subunit | 0.0066 | 0.0034 | 0.0034 |
Echinococcus multilocularis | tachykinin peptides receptor 99D | 0.0299 | 0.0224 | 0.0662 |
Plasmodium falciparum | plasmepsin III | 0.0445 | 0.0343 | 0.225 |
Brugia malayi | aminoadipate-semialdehyde dehydrogenase-phosphopantetheinyl transferase | 0.0099 | 0.006 | 0.1515 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Trichomonas vaginalis | fructose-bisphosphate aldolase, putative | 0.0347 | 0.0263 | 0.1628 |
Brugia malayi | Pepsin A precursor | 0.0445 | 0.0343 | 1 |
Chlamydia trachomatis | holo [acyl-carrier protein] synthase | 0.0028 | 0.0002 | 0.5 |
Giardia lamblia | Prenyltransferase | 0.0066 | 0.0034 | 0.1277 |
Plasmodium vivax | histone acetyltransferase GCN5, putative | 0.0051 | 0.0021 | 0.0123 |
Trypanosoma cruzi | lanosterol synthase, putative | 0.0073 | 0.0039 | 0.0019 |
Entamoeba histolytica | protein farnesyltransferase beta subunit, putative | 0.0066 | 0.0034 | 0.1202 |
Leishmania major | squalene monooxygenase-like protein | 0.0571 | 0.0446 | 0.0446 |
Toxoplasma gondii | histone lysine acetyltransferase GCN5-A | 0.0051 | 0.0021 | 0.0123 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Echinococcus granulosus | Squalene phytoene synthase | 0.3826 | 0.3103 | 1 |
Mycobacterium tuberculosis | holo-[acyl-carrier protein] synthase AcpS (holo-ACP synthase) (CoA:APO-[ACP]pantetheinephosphotransferase) (CoA:APO-[acyl-carrie | 0.0028 | 0.0002 | 0.0007 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Plasmodium vivax | farnesyltransferase beta subunit, putative | 0.0066 | 0.0034 | 0.0207 |
Brugia malayi | aspartic protease BmAsp-1, identical | 0.0445 | 0.0343 | 1 |
Brugia malayi | hypothetical protein | 0.0445 | 0.0343 | 1 |
Plasmodium falciparum | plasmepsin X | 0.0445 | 0.0343 | 0.225 |
Plasmodium falciparum | plasmepsin IX | 0.0445 | 0.0343 | 0.225 |
Brugia malayi | aspartic protease BmAsp-2, identical | 0.0445 | 0.0343 | 1 |
Onchocerca volvulus | 0.0445 | 0.0343 | 0.0929 | |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.1883 | 0.1517 | 0.3341 |
Toxoplasma gondii | aspartyl proteinase (eimepsin), putative | 0.1883 | 0.1517 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0037 | 0.001 | 0.001 |
Schistosoma mansoni | subfamily A1A unassigned peptidase (A01 family) | 0.0445 | 0.0343 | 0.0732 |
Toxoplasma gondii | aspartyl protease | 0.0445 | 0.0343 | 0.225 |
Trypanosoma cruzi | squalene synthase, putative | 1.2275 | 1 | 1 |
Leishmania major | phosphopantetheinyl transferase-like protein | 0.0028 | 0.0002 | 0.0002 |
Brugia malayi | hypothetical protein | 0.0445 | 0.0343 | 1 |
Plasmodium vivax | aspartyl protease, putative | 0.0445 | 0.0343 | 0.225 |
Echinococcus multilocularis | cathepsin d (lysosomal aspartyl protease) | 0.1883 | 0.1517 | 0.4856 |
Plasmodium vivax | aspartyl proteinase, putative | 0.0445 | 0.0343 | 0.225 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0049 | 0.0019 | 0.0019 |
Plasmodium vivax | plasmepsin IV, putative | 0.1883 | 0.1517 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MAD (functional) | = 30 mg kg-1 | Anticonvulsant activity expressed as minimum ataxic dose (MAD) at which mice fell off inverted screen at 30 min post administration | ChEMBL. | 3599026 |
MAD (functional) | = 30 mg kg-1 | Anticonvulsant activity expressed as minimum ataxic dose (MAD) at which mice fell off inverted screen at 30 min post administration | ChEMBL. | 3599026 |
MED (functional) | = 30 mg kg-1 | Anticonvulsant activity expressed as minimum effective dose (MED) against tonic extension produced by maximal electroshock (MES) at 30 min post administration in mice | ChEMBL. | 3599026 |
MED (functional) | = 30 mg kg-1 | Anticonvulsant activity expressed as minimum effective dose (MED) against tonic extension produced by maximal electroshock (MES) at 30 min post administration in mice | ChEMBL. | 3599026 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.